Prospective Case Registry for Wounds
Prospective Observational Registry of Safety and Effectiveness of Acellular Fish Skin Grafts in Treatment of Cutaneous Wounds
Prospective Observational Registry of Safety and Effectiveness of Acellular Fish Skin Grafts in Treatment of Cutaneous Wounds
Sponsor study identifier
observational
300
1 country
1
Study Start
March 17, 2023
Actual (reported)Primary Completion
March 17, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 17, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
This is a post-market, observational and non-interventional registry to collect real-world data in diverse clinical settings and wound applications of acellular fish skin graft (FSG). The registry will be multi-center , target a wide patient population and a variety of wounds to document the quality of wound care, patient outcomes, safety and long-term results.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 17, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 17, 2023
Actual (reported)June 1, 2023
Actual (reported)June 12, 2023
Actual (reported)March 17, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
December 17, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Endpoint : Complete Wound Closure
Is time and frequency of complete wound closure by or on 32 weeks. Complete closure is referred to as full epithelialization with the absence of drainage.
32 weeks
Secondary Endpoints : Reduction in wound area
32 weeks
Reduction in wound depth
32 weeks
Increase in Vascularization
32 weeks
Pain medication use
32 weeks
Number of applications/Cost
32 weeks
Ages above 18 less than 90 years of age who have wounds being treated with FSG.
Kerecis
Arlington, Virginia, 22201, United States
First Submitted
June 1, 2023
First Posted
June 12, 2023
Study Start
March 17, 2023
Actual (reported)Primary Completion
March 17, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
An Exploratory Research on the Efficacy and Safety of Antibacterial Absorbable Dressing in Chronic Non-healing Wounds
Contact the study team to confirm eligibility.
Study Completion
December 17, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
December 30, 2024
Record last verified: 2024-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: